Mylan and Pfizer Say Combined Mylan-Upjohn to Be Called Viatris
November 12 2019 - 1:22PM
Dow Jones News
By Michael Dabaie
Mylan N.V. (MYL) and Pfizer Inc. (PFE) said the name of the new
company to be formed by the planned combination of Mylan and
Pfizer's Upjohn will be Viatris.
Customers and patients will continue to be served by the Mylan
and Upjohn brands for the near future. The new name will be
effective upon closing of the combination, which is expected to
occur in mid-2020, the companies said.
The companies said in July that they agreed to combine Mylan
with Upjohn, Pfizer's off-patent branded and generic established
medicines business, creating a new pharmaceutical company.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
November 12, 2019 13:07 ET (18:07 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mylan NV (NASDAQ:MYL)
Historical Stock Chart
From Apr 2023 to Apr 2024
